THE BALANCEhttps://thebalance.clinic/resources/research/netherlands-mental-health-costs-recovery/

Swiss roots. International expertise. Personal care, delivered with privacy and discretion.

THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Privacy and discretion from the first conversation.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Swiss entrepreneur · Founder & CEO

Clinical resource

Paying for Care Is Only Part of the Bill: The Netherlands’ Mental-Health Outcome Gap

Dutch research estimates €18.8 billion in additional mental-health-related costs and shows why positive care experiences can coexist with limited quality of life. What should families and employers measure?

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

The treatment bill is only one part of mental illness’s cost. Dutch evidence places much of the economic burden in reduced work and daily functioning. A separate patient panel shows another important distinction: people can value professional care while still reporting poor quality of life. For families choosing private treatment, obtaining care and achieving the desired outcome are different questions.

Key findings

€18.8 billion: estimated additional annual costs associated with selected mental-health conditions among Dutch adults aged 18 to 75 in 2022.

€5,630: average additional cost per affected person, including healthcare, travel, and lost productivity or daily functioning.

61% to 85%: the share attributed to productivity losses, depending on the condition. These are modeled costs, not household invoices. [1]

6.3 versus 7.6: the life rating in a separate panel of people with long-term mental-health conditions compared with a general-population reference. About three quarters were satisfied with professional care. [2]

The largest cost can sit outside the treatment room

Estimated additional annual costs by condition group, Netherlands, 2022Mood disorders 6088 euros, ADHD 4405 euros, anxiety disorders 3663 euros, and substance-use disorders 3601 euros per person. Groups overlap and must not be added. Bars start at zero on a 7000-euro scale.NEMESIS-3 economic analysis, 2022 estimatesMood disorders€6,088ADHD€4,405Anxiety disorders€3,663Substance-use disorders€3,601€0€3,500€7,000

These are incremental cost estimates, not the price of a treatment program. People can belong to more than one condition group. Source: Trimbos, November 4, 2025. [1]

The findings support looking beyond appointment attendance. A lower healthcare bill can coexist with continuing problems at work or home. Extra care may also have value without immediately reducing spending.

The analysis does not identify how much of the economic burden could be prevented by a particular intervention. That would require a treatment comparison, not simply a national cost estimate.

A national average is not an executive budget

The €5,630 estimate should not be multiplied by a senior salary to produce an executive mental-health cost. Such a calculation would need evidence about the relevant population, actual work effects, and valuation method.

Income is not the value of every hour affected by symptoms. Family participation, rest, and ordinary activities matter without needing an inflated financial label.

For private-care decisions, ask which benefit the person hopes to achieve and how it will be assessed. A national burden estimate neither sets the appropriate treatment price nor proves that a more expensive program saves more money.

Satisfaction and quality of life tell different stories

Selected findings from the 2025 Psychisch Gezien panel
IndicatorReported finding
Panel participants654 people with long-term mental-health conditions
Average life rating6.3, compared with 7.6 in the population reference
Satisfied with professional careApproximately three quarters
One or more chronic physical conditions60%
Paid employment21%

The panel was reported January 15, 2026. It is not a matched effectiveness trial or a representative sample of affluent households. The indicators overlap. [2]

Almost a quarter reported insufficient professional support. A person can appreciate a clinician’s effort and still need more help. That is not a contradiction, and neither finding should be dismissed.

It also does not prove care caused or failed to reduce the difficulties. Baseline needs and an appropriate comparison are necessary for that conclusion. The immediate reporting lesson is to keep experience, symptoms, and quality of life separate.

First-onset estimates need their own denominator

NEMESIS follow-up research found that around 11% of adults without a previous studied mental-health condition developed one over almost three years. Follow-up included 4,688 participants from an initial 6,194. Researchers translated the findings into approximately 275,000 first cases annually nationwide. That is an annualized survey estimate, not a diagnostic register count. [3]

Initial interviews ran from November 2019 to March 2022, with follow-up between January 2023 and November 2024. Publication in 2025 does not make these 2025 incidence observations.

For comparison with the earlier NEMESIS study, researchers used ages 18 to 64. The roughly three-year first-onset proportion rose from 9% to 14%. Those figures should not be mixed with the broader 18-to-75 estimate as though all share one denominator.

For a family-business discussion, the finding is not a prediction that a successor will become unwell. It supports keeping appropriate assessment and support available through changing life circumstances.

A reporting change is not proof that waiting improved

From January 2026, the Dutch Healthcare Authority began deriving waiting-time information for single-location mental-health providers from claims data rather than their previous manual submissions. Multiple-location providers remain under a transitional arrangement, with broader implementation planned for 2027. [4]

The intended improvement is in measurement and reporting burden. It does not establish that waiting times suddenly disappeared or fell.

Before comparing releases, check whether a figure concerns people still waiting, people who eventually started, or an expected wait reported by a provider. Those are different questions for someone deciding how to obtain care.

For affluent families, the uncertainty is which pathway fits

Being able to pay may widen the available options without clarifying which professional to approach or how several recommendations fit together. The national studies do not measure that experience specifically in HNW households.

A useful proposal explains who assesses the person, which needs take priority, and what happens when the first plan does not help enough. Convenience should not substitute for clinical fit.

Several providers also do not automatically make one coordinated plan. Ask who reconciles recommendations and communicates changes. Administrative availability and qualified clinical oversight are different responsibilities.

Work is one outcome, not the only one

A patient may prioritize sleep, independence, relationships, or a more sustainable distribution of responsibilities. Employment can be part of the plan without becoming its only legitimate goal.

A founder who chooses a different role may have made a considered decision. Someone who resumes the same role may still struggle. Neither outcome is fully described by a payroll record.

The questions should be specific: which responsibilities can be sustained, what support is wanted, and when should the plan be reviewed? A prestigious title is not proof of either wellness or vulnerability.

What a better private-care comparison would show

Proposed outcome questions for patients, families, and referrers
DomainQuestionEvidence
AccessHow quickly does appropriate care begin?Defined start point and eligible population
Clinical changeWhich needs improve?Suitable measures, baseline values, and follow-up
FunctioningWhat can the person sustain?Patient-relevant daily-life outcomes
ExperienceWas care understandable and respectful?Experience measured separately from effectiveness
ContinuityWho follows the person afterward?Accepted handover and actual follow-up coverage

This is a proposed framework, not a ranking of Dutch and foreign providers. THE BALANCE should face the same questions when presenting its own results.

For international care, receiving arrangements should be agreed rather than left as a list of suggestions. The patient should know who remains responsible when the location changes.

What the numbers cannot tell us

The sources do not establish private-care superiority, the cost of distress in a particular family business, or a recovery rate for wealthy people. The economic analysis and patient panel describe different populations and measures. Linking their themes does not make them one dataset.

The bottom line

Measure the life beyond the appointment. Dutch evidence shows why service use and satisfaction can leave important outcomes unanswered. Families should ask what changed, what did not, and who will support the next stage, not simply how many contacts were purchased.

For journalists

Key contrast: modeled costs extend beyond healthcare, while a separate patient panel reports positive care experiences alongside lower quality of life.

Important caveat: these are distinct studies, not a causal evaluation of private treatment.

Suggested attribution: THE BALANCE analysis of published Dutch mental-health evidence.

Methodology and sources

This narrative analysis separates modeled costs, panel experiences, incidence estimates, and reporting-system changes. Source periods and populations remain explicit. No new survey or provider-effect estimate was produced.

  1. Trimbos Institute. Mental-health cost estimates. November 4, 2025.
  2. Trimbos Institute. Psychisch Gezien panel 2025 findings. January 15, 2026.
  3. Trimbos Institute. NEMESIS incidence findings. November 18, 2025.
  4. Dutch Healthcare Authority. Waiting-time reporting changes from 2026.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care